California Liver Research Institute | Pasadena, CA

This study will test a study drug called ALN-PNP with and without another drug that is used for controlling blood sugar, appetite, and weight (for ex...

This study will determine the effect of oral 80 mg resmetirom administered once daily on participants with well-compensated non-alcoholic steatohepat...

This study is researching an investigational drug, ALN-HSD called "study drug". This study is focused on participants who are known to have Metabolic...

The purpose of this study is to assess the safety of atezolizumab and bevacizumab, or atezolizumab alone, as first-line treatment in participants wit...

The purpose of this study is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of efimosfermin in participants wi...

The purpose of this study is to find out how well and safely elafibranor works compared to placebo in adult participants with Primary sclerosing chol...

This study is open to adults who are at least 18 years old living with obesity and have:* a confirmed liver disease called non-alcoholic steatohepati...

The goal of this clinical study is to learn more about the study drug, seladelpar, and its effects on clinical outcomes in participants with primary...

This study will be conducted to assess the safety/tolerability profile of E7386 as a single agent administered orally in participants with selected a...

An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)

The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent...